Explore
← New search
Filters:
Effector
✕
flow-cytometry
✕
mice bearing b16-ova (small and advanced) and mc38-ova tumors
✕
clear all
1 matching publication(s)
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells.
PMID 37081150 · Nat Immunol · 2023
L1
37/100